Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
Portfolio Pulse from
Alnylam Pharmaceuticals will release its Q4 and full-year 2024 financial results on February 13, 2025, before the market opens. A conference call will follow to discuss the results and future expectations.
January 30, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Alnylam Pharmaceuticals is set to release its Q4 and full-year 2024 financial results on February 13, 2025. The announcement will be followed by a conference call discussing the results and future outlook.
The announcement of financial results is a routine event for publicly traded companies. While it provides important information for investors, the actual impact on stock price will depend on the results themselves and the guidance provided during the call.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100